FDA would get $821M boost under HHS budget proposal for 2014

04/12/2013 | MassDevice.com (Boston)

The FDA would receive $4.7 billion for its drug, medical device and biologic surveillance, an $821 million increase over 2012, under a budget proposal released by HHS for 2014. A total of $1.29 billion will go toward the FDA's drug program, $435 million for medtech and $338 million for biologics, which will be supplemented by the user fees paid for new product reviews.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA